Anti-Human IL1B Recombinant Antibody(Canakinumab)_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human IL1B Recombinant Antibody(Canakinumab)

Anti-Human IL1B Recombinant Antibody(Canakinumab)

产品编号

YR1159

别名

科研级 Canakinumab ( 卡那奴单抗 ), Anti-IL1B Recombinant Antibody, Research Grade Canakinumab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Alias	科研级 Canakinumab ( 卡那奴单抗 ), Anti-IL1B Recombinant Antibody, Research Grade Canakinumab
Catalog Number	YR1159
Molecular Name	Canakinumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Kappa
Formulation	PBS, pH7.5
Background	Canakinumab (INN), sold under the brand name Ilaris is a medication for the treatment of systemic juvenile idiopathic arthritis (SJIA) and active Still's disease, including adult-onset Still's disease (AOSD). It is a human monoclonal antibody targeted at interleukin-1 beta. It has no cross-reactivity with other members of the interleukin-1 family, including interleukin-1 alpha.
CAS Number	914613-48-2
Application	FCM, IP, ELISA, Neut, FuncS, IF, IHC
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Molecular Weight	145.2 kDa
Target	IL1B[Homo sapiens]

推荐产品

400-621-6806
614353794
周一至周五 9:00-18:00
0